Ever need a fact or quotation on allografts? Designed for speechwriters, journalists, writers, researchers, students, professors, teachers, historians, academics, scrapbookers, trivia buffs and word lovers, this is the largest book ever created for this single word. It represents a compilation from a variety of sources with a linguistic emphasis on anything relating to the term “allografts,” including non-conventional usage and alternative meanings which capture ambiguities. The entries cover all parts of speech (noun, verb, adverb or adjective usage) as well as use in modern slang, pop culture, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This “data dump” results in many unexpected examples for allografts, since the editorial decision to include or exclude terms is purely a linguistic process. The resulting entries are used under license or with permission, used under “fair use” conditions, used in agreement with the original authors, or are in the public domain. Proceeds from this book are used to expand the content and coverage of Webster’s Online Dictionary (www.websters-online-dictionary.org).

Ever need a fact or quotation on "apples and honey"? Designed for speechwriters, journalists, writers, researchers, students, professors, teachers, historians, academics, scrapbookers, trivia buffs and word lovers, this is the largest book ever created for this word. It represents a compilation of "single sentences" and/or "short paragraphs" from a variety of sources with a linguistic emphasis on anything relating to the term "apples and honey," including non-conventional usage and alternative meanings which capture ambiguities. This is not an encyclopedic book, but rather a collage of statements made using the word "apples and honey," or related words (e.g. inflections, synonyms or antonyms). This title is one of a series of books that considers all major vocabulary words. The entries in each book cover all parts of speech (noun, verb, adverb or adjective usage) as well as use in modern slang, pop culture, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This data dump results in many unexpected examples for "apples and honey," since the editorial decision to include or exclude terms is purely a computer-generated linguistic process. The resulting entries are used under license or with permission, used under fair use conditions, used in agreement with the original authors, or are in the public domain.

Nonfiction Usage

Patent Usage

Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material: Patented by Soo Kyung Chae, Hong Yeoul Kim, Ho Yeon Lee, Chang Hun Lee and Kang Moon Seo on July 5, 2000. Abstract: An artificial bone promotive of osteoanagenesis comprising a calcium phosphate cement and a linear polyphosphate, wherein the calcium phosphate cement comprises .beta.-tricalcium phosphate, monocalcium phosphate, calcium sulfate hemihydrate and other additives. The artificial bone is non-toxic to the body chemically stable, and has an excellent biodegradability. The artificial bone may be applied as substitutes for bone cements, allografts and autografts.

Control of Nk Cell Function and Survival by Modulation of Ship Activity: Patented by William G. Kerr on September 19, 2001. Abstract: Suppression of hematopoietic-specific SH2-containing inositol polyphosphatase (SHIP) activity by genetic and pharmaceutical means is taught for suppression of rejection of, and prevention of graft-versus-host disease in, solid organ allografts or xenotransplants, and histo-incompatible marrow grafts. Also disclosed are methods for the screening of substances and genetic constructs that inhibit SHIP function in mammalian cells, and cell lines and transgenic animals that have the SHIP-/- phenotype.

METHOD OF EVALUATING IMMUNE SYSTEM RESPONSE TO ALLOGRAFTS, VIRAL INFECTION AND IMMUNOSUPPRESSIVE THERAPY: Patented by Andrew J. Cornaby and Roy A. Dempsey on August 1, 1987. Abstract: Detection of solublen Interleukin-2 (IL-2) and Interleukin-2 receptor (IL-2R) levels in the serum, plasma, urine and bile of kidney and liver transplant patients using sensitive immunoassays provides valuable prognostic, monitoring and diagnostic information about impending, acute and chronic or recovering allograft rejection episodes. Additionally, monitoring immune system activation with these sensitive immunoassays can be useful for detecting viral and other infections and for distinguishing cyclosporine toxicity from graft rejection.

Photochemistry for the Preparation of Biologic Grafts-Allografts and Xenografts: Patented by Glenn M. Lamuraglia on September 26, 1996. Abstract: Photodynamic therapy (PDT), a technique to produce cytotoxic free radicals, was used to prepare arterial allografts. After impregnation with the photo-sensitizer chloroaluminum sulfonated phthalocyanine, aortas of ACI rats were PDT-treated and transplanted in Lewis rats. PDT grafts were completely reendothelialized by 4 weeks.

Preparation of inexpensive, HIV-free human skin allograft: Patented by Ernest K. Manders, Andrea M. Koegel and Donald R. Mackay on April 2, 1992. Abstract: A new method for the preparation and sterilization of skin allografts is presented. Human skin allografts are radiated in the present invention and applied as a temporary wound dressing on a graft dome. The invention is particularly useful for wound and burn therapies and presents a low cost, safe, and effective treatment that can be widely used with extensive storage capability.

Treatment of Hepatitis C by Administration of Anti–il–2 Receptor Monoclonal Antibody and an Antiviral Compound: Patented by Antonio Pinna, Camillo Ricordi and Andreas G. Tzakis on October 29, 1999. Abstract: A novel method using anti–interleukin 2 receptor monoclonal antibodies and at least one antiviral compound for treating patients having severe viral hepatitis C is described. The inventive method may be used to treat recurrent hepatitis C following liver transplantation, thereby reducing complications in recipients of liver allografts.

Use of Brequinar and Derivatives in Chronic Rejection of Allografts and Xenotransplantation: Patented by Hendrik Schuurman on May 9, 1997. Abstract: Analogues of brequinar, e.g., of formula (I), are found to be useful in the treatment and prevention of allograft chronic rejection and xenograft hyperacute, acute or chronic rejection.

Bibliographic Usage

Aardema, K. L., et al. "Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests" appears in Transplantation Proceedings written by K. L. Aardema, R. E. Nakhleh, L. K. Terry, E. M. Burd, C. K. Ma, D. K. Moonka, K. A. Brown and M. S. Abouljoud. Published in February - March 1999.

Aarnio, P., et al. "Effects of acute rejection and antirejection therapy on arteries and veins from canine single lung allografts" appears in The Journal of Thoracic and Cardiovascular Surgery written by P. Aarnio, H. Schersten, H. D. Tazelaar, V. M. Miller and C. G. McGregor. Published in June 1996.

Abbas T.M., Wafa E.W., Bakr M.A., Refaie A.F., Sheashaa H.A., Elagroudy A.E., El-Baz M.A., Mohsen T.A., Shehab El Dein A.B., Sobh M.A., Ghoneim M.A. Authors of "Histologic and clinical findings in living donor allografts with long-term stable function," published in American Journal of Nephrology, vol. 26, no. 5, p. 491-6, in 2006.

• Preface iv
• Nonfiction Usage 1
• Patent Usage 1
• Bibliographic Usage 2
• Lexicographic Usage 202
• Index 208